The latest "Globes"-Smith poll shows that Kahlon, Liberman and Lapid could decide who will form the next government.
Bank Leumi is likely to sell at least 9% of Israel Corporation and Kenon's shares in the next five years.
The government appointed committee will recommend closing the water corporations.
Israel's citizens are again waking up to a new reality.
The market may interpret the sale by the outgoing CEO, in dispute with his partner Shraga Biran, as a vote of no confidence.
Dexia: We are committed to a competitive and orderly sale procedure for Dexia Israel to maximize shareholders value.
The Supervisor of Banks is ordering Israeli banks to require foreign residents to declare having paid tax on the money in accounts.
RedHill is buying the rights for the development of a diagnostic Crohn's disease test.
Opko Health, Teva and Israel Chemicals led the market higher as the corporate bond market continued to recover.
Prico: The potential for shekel depreciation against the dollar has not yet been realized.
The Israeli has successfully floated Camden Market, at a company value of £750 million.
Chairman & CEO, Rubicon Business Group Ltd.
Roden explains the popularity of Israeli and Middle Eastern food, and shares her famous orange and almond passover cake recipe.
Yael Andorn believes progress will be made on items that do not require legislation, such as raising the minimum wage.
Cofizz has filed a defense with the trademark registrar on the logo similarity suit as the two discount cafes trade insults.
The GetKids service costs NIS 5.20 and is also available for taxis to Ben Gurion Airport.
Transport & infrastructure
The collaboration will focus on immune checkpoint candidates found by Compugen for potential cancer treatment.
The smart energy system will save 50-75% on the chain's heating and air-conditioning.
MediSafe and TinyTapt were second and third in the Tel Aviv competition.
Relations between Teva and Biotec have deteriorated into a legal dispute and an entanglement with the Russian authorities.
Teva has lost its 180 days exclusivity for the generic version of Pfizer's arthritis and chronic pain treatment.